X4 Pharmaceuticals (XFOR) Interest Coverage Ratio Growth (3y) (2020 - 2025)
X4 Pharmaceuticals (XFOR) Interest Coverage Ratio Growth (3y) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
29.25% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
-16.86% |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
X4 Pharmaceuticals |
156.06 Mn |
156.06 Mn |
2.20 Mn |
21.44% |
| Date | Value |
|---|
| Dec 31, 2025 |
21.44% |
| Sep 30, 2025 |
14.93% |
| Jun 30, 2025 |
19.35% |
| Mar 31, 2025 |
43.10% |
| Dec 31, 2024 |
20.98% |
| Sep 30, 2024 |
11.73% |
| Jun 30, 2024 |
52.64% |
| Mar 31, 2024 |
0.39% |
| Dec 31, 2023 |
18.32% |
| Sep 30, 2023 |
11.91% |
| Jun 30, 2023 |
-1.75% |
| Mar 31, 2023 |
-13.40% |
| Dec 31, 2022 |
-4.05% |
| Sep 30, 2022 |
7.08% |
| Jun 30, 2022 |
5.08% |
| Mar 31, 2022 |
3.79% |
| Dec 31, 2021 |
2.73% |
| Sep 30, 2021 |
28.87% |
| Jun 30, 2021 |
18.08% |
| Mar 31, 2021 |
17.73% |
